2,529
Views
6
CrossRef citations to date
0
Altmetric
Pulmonary Medicine

Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis

, , , , , , , & show all
Pages 1199-1207 | Received 16 Feb 2021, Accepted 24 Jun 2021, Published online: 20 Jul 2021

References

  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940.
  • Choi JY, Rhee CK. Diagnosis and treatment of early chronic obstructive lung disease (COPD). JCM. 2020;9(11):3426.
  • Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717.
  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164.
  • Zheng J. A nationwide questionnaire survey on clinical application of pulmonary function testing in China. Zhonghua Jie He He Hu Xi Za Zhi. 2002;25(2):69–73.
  • Gao Y, Zheng JP, An JY, et al. Investigation on quality of spirometry in 36 large hospitals in China. Zhonghua Jie He He Hu Xi Za Zhi. 2010;33(4):247–250.
  • Enright P. Does screening for COPD by primary care physicians have the potential to cause more harm than good? Chest. 2006;129(4):833–835.
  • US Preventive Services Task Force (USPSTF), Siu AL, Bibbins-Domingo K, Grossman DC, et al. Screening for chronic obstructive pulmonary disease: US preventive services task force recommendation statement. JAMA. 2016;315(13):1372–1377.
  • Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85–95.
  • Tsukuya G, Matsumoto K, Fukuyama S, et al. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study. Allergol Int. 2015;64(1):49–53.
  • Tsukuya G, Samukawa T, Matsumoto K, et al. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study. COPD. 2016;11:1903–1909.
  • Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35.
  • Leeflang MM, Deeks JJ, Gatsonis C, et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008;149(12):889–897.
  • Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–893.
  • Wang JF, Leeflang M. Recommended software/packages for meta-analysis of diagnostic accuracy. J Lab Precis Med. 2019;4:22–22.
  • Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.
  • Sogbetun F, Eschenbacher WL, Welge JA, et al. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease. Respir Med. 2016;120:1–9.
  • Kobayashi S, Hanagama M, Yanai M. Early detection of chronic obstructive pulmonary disease in primary care. Intern Med. 2017;56(23):3153–3158.
  • Llordés M, Zurdo E, Jaén Á, et al. Which is the best screening strategy for COPD among smokers in primary care? COPD. 2017;14(1):43–51.
  • Spyratos D, Haidich AB, Chloros D, et al. Comparison of three screening questionnaires for chronic obstructive pulmonary disease in the primary care. Respiration. 2017;93(2):83–89.
  • Soriano JB, Molina J, Miravitlles M. Combining case-finding methods for COPD in primary care: a large, two-stage design study. Int J Tuberc Lung Dis. 2018;22(1):106–111.
  • Beaumont JL, Victorson D, Su J, et al. Examining web equivalence and risk factor sensitivity of the COPD population screener. Value Health. 2011;14(4):506–512.
  • Sui CF, Ming LC, Neoh CF, et al. VitalQPlus: a potential screening tool for early diagnosis of COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1613–1622.
  • Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.